Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Top Cited Papers
- 10 November 2009
- journal article
- review article
- Published by Elsevier in Neurobiology of Disease
- Vol. 37 (3) , 510-518
- https://doi.org/10.1016/j.nbd.2009.11.004
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegenerationProceedings of the National Academy of Sciences, 2009
- Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson DiseaseJournal of Neuropathology and Experimental Neurology, 2008
- Minocycline and neurodegenerative diseasesPublished by Elsevier ,2008
- The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discoveryFundamental & Clinical Pharmacology, 2008
- Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokinesBrain, Behavior, and Immunity, 2008
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's diseaseNature Genetics, 2008
- Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's diseaseProceedings of the National Academy of Sciences, 2007
- Non-steroidal anti-inflammatory drugs in Parkinson's diseaseExperimental Neurology, 2007
- Inflammation as a causative factor in the aetiology of Parkinson's diseaseBritish Journal of Pharmacology, 2007
- Opioid receptors in midbrain dopaminergic regions of the rat I. MU receptor autoradiographyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993